p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage.

Jean-Christophe Bourdon (1) , Mustapha Aoubala (1) , Fiona Murray-Zmijewski (1) , Marie P. Khoury (1) , Kenneth Fernandes Fernandes (1) , Stephane Perrier (1) , Hugo Bernard (1) , Anne-Catherine Prats (1) , David P Lane (1)

1 Centre of Oncology and Molecular Medicine

We have previously reported that the human p53 gene encodes at least nine different p53 isoforms, including Δ133p53α, which can modulate p53 transcriptional activity and apoptosis. In this study, we aimed to investigate the regulation of Δ133p53α isoform expression and its physiological role in modulating cell cycle arrest and apoptosis. We report here that in response to a low dose of doxorubicin (which induces cell cycle arrest without promoting apoptosis), p53 directly transactivates the human p53 internal promoter, inducing Δ133p53α protein expression. The induced Δ133p53α then inhibits p53-dependent apoptosis and G1 arrest without inhibiting p53-dependent G2 arrest. Therefore, endogenous Δ133p53α does not exclusively act in a dominant-negative manner toward p53 but differentially regulates cell cycle arrest and apoptosis.

Mots clés: splicing; cell cycle arrest; transactivation; isoforms; apoptosis

Jean-Christophe Bourdon, Mustapha Aoubala, Fiona Murray-Zmijewski, Marie P. Khoury, Kenneth Fernandes Fernandes, et al.. p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage.. Cell Death and Differentiation, 2010, ⟨10.1038/cdd.2010.91⟩. ⟨hal-00563512⟩